Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Methyl Propionate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel serine-based route for methyl 2,3-diaminopropionate. Mild conditions, high yield, scalable process for peptidomimetic inhibitor manufacturing.
Novel serine-based route for methyl 2,3-diaminopropionate offers cost reduction and mild conditions for peptide inhibitor manufacturing.
Novel route for palovir intermediate using protected bromoethylamine. High selectivity, mild conditions, and scalable process for API manufacturing.
Patent CN116003467A reveals high-TON triphosphine ligands for olefin alkoxycarbonylation, enabling cost-effective pharma intermediate manufacturing.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.
Novel boron-catalyzed condensation and low-temp cyclization for high-purity remimazolam intermediates, offering scalable supply chain solutions.
Patent CN112209850A details an efficient NHC-catalyzed asymmetric synthesis route for beta-amino acid intermediates, offering superior chiral control and scalable manufacturing capabilities for global supply chains.
Patent CN103539730A reveals scalable routes for Dabigatran intermediates using metal reduction or amine-promoted hydrogenation, ensuring supply continuity.